Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017)

Table 2 Comparison of imaging features of HCCs in LI-RADS: Gadoxetic acid and gadopentetate dimeglumine

Major HCC features	Gadoxetic acid	gadopentetate dimeglumine	P value
Capsule appearance	3.4(5/145)	5.5(8/145)	0.793
Arterial hyperenhancement	89(129/145)	89(129/145)	1.000

Data are percentages (numbers used to calculate percentages. Data werer compared using the Wilcoxon test. Significant value, P < 0.05

ISSN: 1470-7330